Free Submission Public Relations &
Deutsch English

Computer & Technology

Digisonics and Medis Partner to Provide Comprehensive Solution for Cardiovascular MR Workflow

Print article Print article
2013-12-19 21:52:52 - Digisonics and Medis announce a partnership to provide an integrated system solution for cardiovascular MR workflow.

Digisonics and Medis are proud to announce a partnership to provide a comprehensive single system solution for image analysis and structured reporting of pediatric and adult CV MR studies. The integrated system solution between Digisonics and Medis will result in a seamless, efficient MR workflow.

Users will have access to fast image review and analysis of their MR studies via the Medis QMass® ES advanced quantitation software which provides built-in disease-oriented review layouts and cross referencing tools. Users can analyze cardiovascular dimensions and morphology, myocardial function (MR & CT), phase-contrast blood flow, tissue characterization1 (late enhancement, T2 weighted edema, T2/T2* mapping, T1 mapping), myocardial perfusion1 and MR angiography. Results from the analysis completed in Medis will be saved directly back

into the Digisonics cardiovascular information system.

With the completed image analysis from Medis, clinicians can then quickly summarize their findings in a structured report using Digisonics’ easy-to-navigate picklists and summary macros. These concise (usually one-page) and highly-configurable reports also offer the ability to embed post-processed study images and graphics such as charts or clinical diagrams.

“Digisonics is excited to partner with Medis in offering the most comprehensive combination of Cardiac MR imaging and reporting functionality on the market,” said Steve Dissing, Director of Sales and Marketing at Digisonics. “Combining Digisonics’ 39 years of experience in structured reporting with the MR imaging toolset from Medis will provide clinicians and researchers the comprehensive analysis, reporting and data mining capabilities they require.”

“This solution combines Digisonics’ outstanding reporting and data mining capabilities with our long-term available gold standard quantitative analysis and post processing tools providing a comprehensive and efficient solution for both clinicians and researchers,” said Daniel Garcia Miranda, VP Corporate Marketing & Sales at Medis.

QMass is a registered trademark of Medis medical imaging systems bv in the United States and in other countries. QMass is cleared for market in the US.

1 The use of contrast agent for cardiovascular MR procedures is not FDA-approved, therefore, the myocardial perfusion and tissue characterization modules of QMass have not received US 510(k) market clearance.

Myocardial perfusion and tissue characterization modules are available on demand in the US for research purpose only.

About Digisonics, Inc.
Digisonics provides top-rated clinical image management and structured reporting systems for cardiovascular (CVIS), radiology, and obstetrics & gynecology. Digisonics structured reporting solutions combine high performance image review workstations, a powerful PACS image archive, an integrated clinical database, comprehensive analysis capabilities and highly configurable reporting for multiple modalities. Key applications are complemented with interfaces to information systems and 3rd party vendors, providing facilities with a seamless, efficient clinical workflow.

About Medis
Medis is a privately owned company, which was founded in 1989 as a spin-off of the Leiden University Medical Center's Division of Image Processing (LKEB), Department of Radiology. Medis provides software solutions that enable clinicians, technicians and researchers to accurately quantify medical images. Medis' solutions help improve the quality of diagnosis, treatment planning and patient follow-up. They help drive innovations in research and assess the effectiveness of new treatments and devices.

Press Information:

3701 Kirby Drive

Contact Person:
Dora Wu
Phone: 800-940-3240
email: email


Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact | BidVertiser